Find Clinical Trials & Studies

Visit the Research & Education Institute

Safety, Efficacy, and PK of EVOLVE104 in Advanced Urothelial and Squamous Cell Carcinomas

I'm Interested!

Please call
1-866-373-1464

A Phase 1 Dose-Escalation and Expansion Study Evaluating the Safety, Efficacy, and Pharmacokinetics of EVOLVE104 in Subjects With Advanced Urothelial and Squamous Cell Carcinomas

Sex: Any
Age: Adult (18 - 64), Older Adult (65+)
Accepting Healthy People: No
Type: Interventional / Therapeutic
Trial Phase: Phase I
Conditions Being Studied: Cancer - Urethral

Study Purpose

The goal of this study is to evaluate the safety and effectiveness of EVOLVE104 in participants with advanced urothelial and squamous cell carcinomas who have previously taken standard treatment options, have declined or have been ineligible for treatment with these medications. Participants with advanced or metastatic cancer who meet all eligibility criteria may be eligible to participate in the study.

Principal Investigator
Jameel Muzaffar MD

Department/Division
Cancer (Genitourinary)

UH IRB: STUDY20260496
StudyID: EVIM1Y26
ClinicalTrials.gov: NCT07217171

I'm Interested!

Please call
1-866-373-1464

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-866-373-1464